{
  "docId": "019de073-5c75-763a-a0f1-d995dc5da488",
  "docSlug": "01bee26c2c6ee992ec5e01a8e02dc689",
  "documentTitle": "Myovant Sciences | Results Presentation Deck | 34 slides",
  "authorId": "myovant-sciences",
  "authorName": "Myovant Sciences",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 31,
  "pageCount": 34,
  "prevPage": 30,
  "nextPage": 32,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a visual comparison matrix to highlight the 'one pill, once-a-day' value proposition.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-5c75-763a-a0f1-d995dc5da488/31",
  "deckHref": "/decks/019de073-5c75-763a-a0f1-d995dc5da488",
  "deckJsonHref": "/decks/019de073-5c75-763a-a0f1-d995dc5da488.json",
  "deckAnchorHref": "/decks/019de073-5c75-763a-a0f1-d995dc5da488#slide-31",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.2,
        "y": 0.45
      },
      "kind": "callout",
      "text": "One brand, one dose, one pill, once-a-day",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "055b8902-05ea-4850-b6b7-2e79e852aecd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.07,
        "y": 0.9
      },
      "kind": "disclaimer",
      "text": "GnRH = Gonadotropin-releasing hormone; E2/N = Estradiol and norethindrone acetate; mg = milligram; QD = Once-daily NOTE: Chart not intended to make any implied or direct comparative conclusions between MYFEMBREE and any other product.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ee77bda-118f-4fd1-90c2-e53159b50cbd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.82,
        "x": 0.09,
        "y": 0.23
      },
      "kind": "table",
      "text": "Comparison matrix of MYFEMBREE vs Other GnRH Antagonist Brands across Uterine Fibroids and Endometriosis",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d7a376b-03b3-4a42-b87a-d20ca8a05995",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Simplicity Across Indications Sets MYFEMBREE Apart",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d86465f1-d039-433a-b8ec-7af897c3646c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "07945cde-1136-4ea6-a4b2-ccac49b8afe9",
      "evidence": "Direct visual comparison between MYFEMBREE and competitors",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}